Bright Path Laboratories, Inc. (privately held) 3-year-old startup contract manufacturer – with offices in both Charlotte and Santa Fe, N.M. – recently got a strong show of support from The U.S. Food and Drug Administration for its patented spinning-tube-in-tube (STT) continuous-flow reactor.
The agency accepted the system, the only one of its kind that manufactures active pharmaceutical ingredients (APIs), into the FDA’s Emerging Technology Program. That program promotes innovative approaches to pharmaceutical product design and manufacturing.
For the full article from the North Carolina, Biotech Center see www.ncbiotech.org/news/bright-path-laboratories-develops-new-way-produce-active-pharmaceutical-ingredients.
